Mail

Singapore markets closed

Straits Times Index
3,323.20
-6.89(-0.21%)
S&P 500
5,306.04
+1.32(+0.02%)
Dow
38,852.86
-216.74(-0.55%)
Nasdaq
17,019.88
+99.08(+0.59%)
Bitcoin USD
67,778.68
-788.31(-1.15%)
CMC Crypto 200
1,464.36
-20.34(-1.37%)

BMY Jun 2024 50.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

5.20

0.00

(0.00%)

As of 12:56PM EDT. Market open.

Previous close	5.20
Open	5.29
Bid	0.00
Ask	0.00
Strike	50.00

Expiry date	2024-06-14
Day's range	5.20 - 5.29
Contract range	N/A
Volume	2
Open interest	N/A

Business Wire
Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
PRINCETON, N.J., May 29, 2024--Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line...
Business Wire
Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms
PRINCETON, N.J., May 23, 2024--Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications....
Simply Wall St.
Does Bristol-Myers Squibb (NYSE:BMY) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...